Cargando…

Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms

In this stability-indicating, reversed-phase high-performance liquid chromatographic method for flupiritine maleate, forced degradation has been employed and the formed degradants were separated on a C(18) column with a 80:20% v/v mixture of methanol-water containing 0.2% (v/v) triethylamine; the pH...

Descripción completa

Detalles Bibliográficos
Autores principales: Peraman, Ramalingam, Lalitha, K. V., Raja, Naga Mallikarjuna, Routhu, Hari Babu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Österreichische Apotheker-Verlagsgesellschaft 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065123/
https://www.ncbi.nlm.nih.gov/pubmed/24959399
http://dx.doi.org/10.3797/scipharm.1310-01
_version_ 1782322035199836160
author Peraman, Ramalingam
Lalitha, K. V.
Raja, Naga Mallikarjuna
Routhu, Hari Babu
author_facet Peraman, Ramalingam
Lalitha, K. V.
Raja, Naga Mallikarjuna
Routhu, Hari Babu
author_sort Peraman, Ramalingam
collection PubMed
description In this stability-indicating, reversed-phase high-performance liquid chromatographic method for flupiritine maleate, forced degradation has been employed and the formed degradants were separated on a C(18) column with a 80:20% v/v mixture of methanol-water containing 0.2% (v/v) triethylamine; the pH was adjusted to 3.1. The flow rate was 1 mLmin(−1) and the photodiode array detection wavelength was 254 nm. Forced degradation of the drug was carried out under acidic, basic, thermal, photolytic, peroxide, and neutral conditions. Chromatographic peak purity data indicated no co-eluting peaks with the main peaks. This method resulted in the detection of seven degradation products (D1–D7). Among these, three major degradation products from acidic and basic hydrolysis were identified and characterized by (1)H-NMR, (13)C-NMR, and mass spectral data. The method was validated as per International Conference on Harmonization guidelines (Q2). The linearity of the method was in the concentration range of 20–120 μgmL(−1). The relative standard deviations for intra- and interday precision were below 1.5%. The specificity of the method is suitable for the stability-indicating assay.
format Online
Article
Text
id pubmed-4065123
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Österreichische Apotheker-Verlagsgesellschaft
record_format MEDLINE/PubMed
spelling pubmed-40651232014-06-23 Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms Peraman, Ramalingam Lalitha, K. V. Raja, Naga Mallikarjuna Routhu, Hari Babu Sci Pharm Research Article In this stability-indicating, reversed-phase high-performance liquid chromatographic method for flupiritine maleate, forced degradation has been employed and the formed degradants were separated on a C(18) column with a 80:20% v/v mixture of methanol-water containing 0.2% (v/v) triethylamine; the pH was adjusted to 3.1. The flow rate was 1 mLmin(−1) and the photodiode array detection wavelength was 254 nm. Forced degradation of the drug was carried out under acidic, basic, thermal, photolytic, peroxide, and neutral conditions. Chromatographic peak purity data indicated no co-eluting peaks with the main peaks. This method resulted in the detection of seven degradation products (D1–D7). Among these, three major degradation products from acidic and basic hydrolysis were identified and characterized by (1)H-NMR, (13)C-NMR, and mass spectral data. The method was validated as per International Conference on Harmonization guidelines (Q2). The linearity of the method was in the concentration range of 20–120 μgmL(−1). The relative standard deviations for intra- and interday precision were below 1.5%. The specificity of the method is suitable for the stability-indicating assay. Österreichische Apotheker-Verlagsgesellschaft 2014 2013-12-09 /pmc/articles/PMC4065123/ /pubmed/24959399 http://dx.doi.org/10.3797/scipharm.1310-01 Text en © Peraman et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Peraman, Ramalingam
Lalitha, K. V.
Raja, Naga Mallikarjuna
Routhu, Hari Babu
Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms
title Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms
title_full Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms
title_fullStr Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms
title_full_unstemmed Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms
title_short Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms
title_sort identification of degradation products and a stability-indicating rp-hplc method for the determination of flupirtine maleate in pharmaceutical dosage forms
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065123/
https://www.ncbi.nlm.nih.gov/pubmed/24959399
http://dx.doi.org/10.3797/scipharm.1310-01
work_keys_str_mv AT peramanramalingam identificationofdegradationproductsandastabilityindicatingrphplcmethodforthedeterminationofflupirtinemaleateinpharmaceuticaldosageforms
AT lalithakv identificationofdegradationproductsandastabilityindicatingrphplcmethodforthedeterminationofflupirtinemaleateinpharmaceuticaldosageforms
AT rajanagamallikarjuna identificationofdegradationproductsandastabilityindicatingrphplcmethodforthedeterminationofflupirtinemaleateinpharmaceuticaldosageforms
AT routhuharibabu identificationofdegradationproductsandastabilityindicatingrphplcmethodforthedeterminationofflupirtinemaleateinpharmaceuticaldosageforms